KEGG   DRUG: Pertuzumab, trastuzumab and hyaluronidase
Entry
D11934            Mixture   Drug                                   
Name
Pertuzumab, trastuzumab and hyaluronidase;
Pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination);
Pertuzumab, trastuzumab and hyaluronidase-zzxf;
Phesgo (TN)
Product
PHESGO (Genentech)
Component
Pertuzumab [DR:D05446], Trastuzumab [DR:D03257], Hyaluronidase (human recombinant) [DR:D06604]
Remark
Therapeutic category: 4291
ATC code: L01FY01
Product: D11934<JP/US>
Efficacy
Antineoplastic
  Disease
Breast cancer [DS:H00031]
  Type
Monoclonal antibody, combination
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    L01FY Combinations of monoclonal antibodies and antibody drug conjugates
     L01FY01 Pertuzumab and trastuzumab
      D11934  Pertuzumab, trastuzumab and hyaluronidase <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Monoclonal Antibody/Antibody-Drug Conjugate
   Hyaluronidase/ Pertuzumab/ Trastuzumab
    D11934  Pertuzumab, trastuzumab and hyaluronidase
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D11934  Pertuzumab, trastuzumab and hyaluronidase
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11934
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11934
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system